Autres langues Compumedics Limited

Actions

CMP

AU000000CMP2

Equipement et technologie médicale avancés

Marché Fermé - Australian S.E. 07:30:14 03/09/2026			Varia. 5j.	Varia. 1 janv.
0,2350 ^AUD	-14,55%		-7,84%	-29,85%

25/08	Compumedics Limited publie ses résultats annuels pour l'exercice clos le 30 juin 2026	CI
25/08	Compumedics : hausse de l'EBITDA et du chiffre d'affaires pour l'exercice 2026	MT

Autres langues

25/08	Compumedics Limited Reports Earnings Results for the Full Year Ended June 30, 2026
25/08	Compumedics Fiscal 2026 EBITDA, Revenue Up
25/08	Compumedics Limited Reaffirms Financial Guidance for the Fiscal Year 2027
06/07	Compumedics Limited Revises Earnings Guidance for the Fiscal Year 2026
06/07	Compumedics Limited Announces Resignation of Christopher R. Barys as Non-Executive Director, Effective 30 June 2026
06/07	Compumedics Limited Provides Earnings Guidance for the Fiscal Year 2027
09/06	Compumedics Limited Announces Appointment of Mike Stone as Chief Commercial Officer for Its US Operations
21/04	Compumedics Sees Fiscal Year 2026 EBITDA of Up to AU$7 Million
21/04	Compumedics updates FY26 EBITDA guidance A$5.5 million-A$7 million
21/04	Compumedics Limited Updates Earnings Guidance for the Fiscal Year 2026
24/02	Compumedics Limited Reports Earnings Results for the Half Year Ended December 31, 2025
29/01	Compumedics Secures AU$4.2 Million Order for Orion LifeSpan MEG System
29/01	Compumedics secures new A$4.2 million MEG sales order
22/01	Compumedics posts revenue of A$30.8 million for H1FY26
21/01	Compumedics Limited Provides Earnings Guidance for the Fiscal Year 2026
10/11	Compumedics secures new A$4.9 million MEG sales order
30/10/25	Compumedics Limited Elects Mr. Christopher Barys as Director
15/10/25	Compumedics Raises Over AU$2 Million Via Placement
15/10/25	Compumedics raises a$2.15 million via placement at a$0.285 per share
12/10/25	Compumedics seeks trading halt pending capital raising announcement
22/09/25	Compumedics Ltd expects FY26 revenue to exceed A$70 mln with Ebitda of A$9 mln
22/09/25	Compumedics Limited Provides Earnings Guidance for the Fiscal Year 2026
22/09/25	Compumedics Limited Appoints Christopher R. Barys as Non-Executive Director, Effective 22 September 2025
04/09/25	Compumedics says U.S. FDA granted 510(k) clearance for Somfit D device (K252383)
04/09/25	Compumedics' Sleep Testing Device Receives US FDA Clearance